JPMorgan Chase & Co. increased its stake in shares of Columbia Research Enhanced Core ETF (NYSEARCA:RECS – Free Report) by 5.9% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 726,737 shares of the company’s stock after purchasing an additional 40,811 shares during the period. JPMorgan Chase & Co. owned approximately 0.70% of Columbia Research Enhanced Core ETF worth $29,324,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Jane Street Group LLC grew its position in Columbia Research Enhanced Core ETF by 49,303.3% in the 2nd quarter. Jane Street Group LLC now owns 16,658,312 shares of the company’s stock worth $612,859,000 after purchasing an additional 16,624,593 shares during the period. Ameriprise Financial Inc. boosted its stake in shares of Columbia Research Enhanced Core ETF by 22.3% in the 2nd quarter. Ameriprise Financial Inc. now owns 12,963,845 shares of the company’s stock worth $476,940,000 after buying an additional 2,368,065 shares during the last quarter. Bogart Wealth LLC grew its holdings in shares of Columbia Research Enhanced Core ETF by 1,032.2% in the third quarter. Bogart Wealth LLC now owns 2,224,366 shares of the company’s stock worth $89,753,000 after acquiring an additional 2,027,908 shares during the period. Commonwealth Equity Services LLC increased its position in Columbia Research Enhanced Core ETF by 77.3% during the second quarter. Commonwealth Equity Services LLC now owns 2,517,266 shares of the company’s stock valued at $92,610,000 after acquiring an additional 1,097,173 shares during the last quarter. Finally, Raymond James Financial Inc. lifted its holdings in Columbia Research Enhanced Core ETF by 15.3% in the second quarter. Raymond James Financial Inc. now owns 3,167,950 shares of the company’s stock valued at $116,549,000 after acquiring an additional 419,812 shares during the period.
Columbia Research Enhanced Core ETF Stock Performance
Shares of NYSEARCA:RECS opened at $40.89 on Friday. Columbia Research Enhanced Core ETF has a 52-week low of $28.64 and a 52-week high of $41.81. The stock has a market capitalization of $5.02 billion, a price-to-earnings ratio of 22.01 and a beta of 0.95. The stock’s 50-day simple moving average is $41.13 and its two-hundred day simple moving average is $40.49.
About Columbia Research Enhanced Core ETF
The Columbia Research Enhanced Core ETF (RECS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000. The index uses multifactor selection and market cap weighting. RECS was launched on Sep 25, 2019 and is managed by Columbia.
Further Reading
- Five stocks we like better than Columbia Research Enhanced Core ETF
- The gold chart Wall Street is terrified of…
- This makes me furious
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Want to see what other hedge funds are holding RECS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Columbia Research Enhanced Core ETF (NYSEARCA:RECS – Free Report).
Receive News & Ratings for Columbia Research Enhanced Core ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Columbia Research Enhanced Core ETF and related companies with MarketBeat.com's FREE daily email newsletter.
